Silexion Therapeutics Corp
(NASDAQ: SLXN)
Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
3.020
-0.147
(-4.64%)
Range
2.980 - 3.225
(8.22%)
Open
3.180
Previous Close
3.167
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
42,380
Value
-
Remark
Delayed prices. Updated at 06 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
